Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good stuff - the merger is coming - more "interested parties" showing up here :)
Thanks for sharing those with the board buc
No, not that tough to understand. "Hey, we have a facility that's really close to a major port, so we can ship product out to the EU and rest of the globe easily. Here's a picture so you can see what it looks like."
Nice - enjoy the family time!
Why would you think that. You think as soon as the merger goes through they break ground? You don't think there's any setup involved before they break ground - it just magically starts immediately after the merger is announced? Nothing starts immediately. Even just the paperwork and regulatory hurdles involved could take that long.
I think the point of that map was to show the facility in Jumilla will have access to the Port of Cartagena, which is a major shipping hub in the region. So, if the Jumilla facility has product to ship it can do so via the nearby port. If you're looking for breakdowns by types of cargo they handle (e.g. liquid bulk, solid bulk, general cargo, containerized cargo, etc. etc.) you can probably look that up online. But I think the point of the guy who tweeted that map out was to show the strategic location of the IGEX facility in Jumilla relative to it's proximity to the Port of Cartagena. So they can ship their product out. Pretty simple point, I thought.
Good question, and it seems like they chose a good location. I mean, if the facility was in Alabama I'd be stratching my head a bit I confess. But near a major port? Some people might get the idea it opens the European market up for them a bit (and even global to some extent :)
Super clean - zero complaints here in that regard - and again - compared to most other OTC tickers? Parked some $$ here before the bigger announcements hit ;)
Ahh - that's what I meant to link - good catch - appreciate you and Mick bringing that one here - great reminder of what IGEX is putting into place. I've been "invested" and traded so many crappy OTC tickers before... what IGEX has been putting together and communicating via 8K's blows 99% of them out of the water.
mic drop lol -
Yup - pretty funny
just cuz you say it doesn't make it so, even when you lol about it ;)
if if if - by any reasonable standard it sure looks like IGEX is on the cusp of a great merger. That's a lot more than "if". BUT, those with such extreme doubts have an option: don't invest!
Retail action, not dilution. All good here on that front.
My take - the r/m could happen at any time. Not drawn out for very long. The building blocks are now in place...
You can see those guys a mile away, but to see it spelled out so clearly... what a POS.
He only has 27,000 followers, probably a rookie at this lol
Super stoked on the $IGEX merger coming… #lithium and #graphene will only be in higher demand….one of my only long #otc … #clowncollege been crushing day trades so it’s easy to hold while you stack… it’s a great long IMO ❤️😊
— Silky 2.0 (@SilkLifeMedSpa) February 11, 2022
IGEX in "bargain territory" - until it's not.
Was looking to add a bit here and there - my little 500k 0045 bid - no one wanted it - wonder why?
Your man pepto...
Bismo Funyuns
@BismoFunyuns44
·
9m
https://otcmarkets.com/stock/IGEX/news/The-Mineral-Company-LTD-filed-8-K-Form-announcing-important-acquisitions?id=343211
This is massive. This has the potential to be the banger of bangers.
Just to be clear:
-current pub traded euro co
-private Spanish co
-$IGEX locations in US & ES
I hope you see why this is so complicated & time consuming..
.50 by EOY
https://mobile.twitter.com/BismoFunyuns44
The merger will tell all - but we know they have the land and water rights in that specific area for lithium etc. - all signs point to a this being with a major player in that market. Funded by preferred shares. Meanwhile, retail can buy - for now - IGEX in the .004's
I honestly thought that one was a pipe dream a few months ago when it was first floated - but it looks more and more likely now. Unreal!
The Mineral Company LTD filed 8-K Form announcing important acquisitions
Press Release | 02/11/2022
Greenwood Village, CO February 11, 2022 The Mineral Company Ltd. (f/k/a Indo Global Exchange(s) Pte. LTD) (the Company) (OTC PINK:IGEX) is pleased to announce that the Company has filed two (2) SEC Form 8-K after acquiring two very important and strategic assets, which are critical to the success of the anticipated fusion/merger between Igex, a European publicly traded company and well established leader in the lithium and energy storage, and a Spanish company involved primarily in the graphene manufacturing industry. The parties have been working hard on this strategic fusion/merger, and the assets acquisition, which are essential to the successful development of the premier center for manufacturing, storage, and shipping of minerals with emphasis in lithium, graphene, and its derivatives in Southern Europe. Engineers and architects are already retained to work on all necessary plans and permits with the goal to break ground in less than 6 months aiming at having the first phase of the project completed and operational by year-end 2022. The lot(s) are located in an already approved "urban" zone, thus not requiring rezoning applications. The construction of the center is permitted under the current zoning.
The first 8-K was filed on February 2, 2022, to report the acquisition of a a 50,000 sqm (or 538,196 SQ FT) lot located in Jumilla, Spain for a total of 300,000.00 plus approximately an 11% RE tax assessment. The property is worth approximately 980,000 as reported independently by Arquitasa (Sociedad de Tasacin), which has been homologated by Banco de Espaa. The transaction was financed by the Seller, in a 7-year term loan at 2% per annum, guaranteed by one of Igex Preferred Shareholder. The Source of repayment will from revenues generated.
IGEX filed a second SEC 8-K Form to report the acquisition of water rights over the above referenced lots, underground water reservoir, and existing extraction station, including 2 industrial water pumps for a total of 100,000.00. The transaction was financed by the seller at a 2% interest per annum for a period of 84 months. This transaction was also made possible by one of our preferred shareholders, who is personally guarantying the financing. This acquisition was a strategic and necessary one as water is paramount to lithium and other minerals extraction and production.
https://www.otcmarkets.com/stock/IGEX/news/The-Mineral-Company-LTD-filed-8-K-Form-announcing-important-acquisitions?id=343211
Regen BioPharma, Inc. to Initiate Development of its Modified mRNA anti-Cancer Vaccine Technology
SAN DIEGO, Feb. 11, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC:RGBP) and (OTC:RGBPP) is embarking on a development program to commercialize its modified mRNA anti-cancer vaccine targeting the Survivin protein. In the first phase of the development program, Regen will design and have experiments carried out that will form the initial series of pre-clinical studies required as part of an FDA IND submission.
The patented technology (patent issued in Aug, 2021) is a cellular vaccine that uses a modified mRNA molecule expressing peptides of Survivin which are exposed to dendritic cells. These dendritic cells are then matured and infused into the cancer patient's circulation where they are expected to home in on the cancer and destroy it. There are currently several clinical trials ongoing in the U.S. and Europe using Survivin as a vaccine for multiple different cancers which further supports this approach.
Survivin is the smallest member of the Inhibitor of apoptosis (IAP) family of proteins, involved in inhibition of apoptosis (a form of programmed cell death that occurs in multicellular organisms) and regulation of cell cycle. These functional attributes make Survivin a unique protein regulating cell proliferation and cell death. Expression of Survivin in tumors correlates with not only inhibition of apoptosis and a decreased rate of cell death, but also resistance to chemotherapy and aggressiveness of tumors. Therefore, Survivin is an important target for cancer vaccines and therapeutics.
"Although these are early steps, I am very pleased that we can begin the scientific and regulatory pathways of getting this newly patented technology into the clinic," says David Koos, CEO and Chairman of Regen. "This technology has been out-licensed for use in pancreatic cancer which leaves Regen dozens of other potential indications."
About Regen BioPharma Inc.:
Regen BioPharma, Inc. is a publicly traded biotechnology company (OTC:RGBP) and (OTC:RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
CONTACT INFORMATION
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-722-5505 Phone
+1-619-330-2328 Fax
http://www.regenbiopharma.com
david.koos@regenbiopharma.com
https://newsfilter.io/a/bd023e5795a93f1b74a3c9892d6c1425
Unreal - that's so good.
Nice - betcha made a boatload on that one - and those who didn't get shaken out.
That's a good one - and certain types here just stumble over themselves with glee when it's red with the "I told you so's" - then mysteriously go quiet for the big green days. Wonder why?
Great write-up there and I agree.
Yep, lol - and possessed by a spirit of schadenfreude. But I'm with you on this one CJ, and appreciate your fighting the good fight on this IGEX board!
I agree with that... and
As long as it wasn’t dilution, I really don’t care. I still whole heartedly believe in the DD. They just need to come out with a lengthy PR and just say it. $igex @IGEX_Official
— Bismo Funyuns 🇺🇸 (@BismoFunyuns44) February 9, 2022
Friday "long PR" - let's see what they're rolling out here. They're obviously putting some bigger deals together. Little later than what they were projecting so the OTC market does what it does - but I'll be here :)
$IGEX @IGEX_Official https://t.co/0cbTVyEAE0
— Bismo Funyuns 🇺🇸 (@BismoFunyuns44) February 9, 2022
They are setting themselves up perfectly for a merger. Now we need the PR for details.
"development of the biggest center in southern Europe for storage, shipping, and development of minerals (particularly lithium, graphene, and its derivatives, located in Jumilla, Spain;"
bouncing off the ascending 5OMA support like a champ as the bollies are tightening up: https://schrts.co/RXUqvqnk